Memorial Sloan Kettering Cancer Center SC - LXH254X2101

New York, New York 10065

0 studies enrolling now · 1 studies all time

What they study most

Melanoma, NSCLC, Other Solid Tumors, Ovarian Cancer

Studies at this site

• Phase I Study of LXH254 in Patients With Advanced Solid Tumors Haboring MAPK Pathway Alterations — Stopped early